Have you noticed granulomatous reactions becoming more common with the rise in peptide-based and nano-technology topical formulations, along with increased use of resurfacing devices outside of physician oversight?

Are there specific risk factors with certain topicals in post-procedure care that we should be aware of to help prevent granulomatous reactions?